| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $56,659,180 ) (Continued on the next page) |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS105715 | Sensitization of developing sensory neurons after incision | 000 | 8 | NIH | 3/31/2026 | $413,504 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 009 | 4 | NIH | 4/3/2026 | $680,919 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 008 | 4 | NIH | 4/2/2026 | $135,660 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 007 | 4 | NIH | 4/2/2026 | $62,634 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AG093208 | The Effect of DDX41 Mutations on Hematopoiesis During Aging | 000 | 1 | NIH | 3/27/2026 | $640,060 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL179869 | The contribution of JNK signaling to development of EPR dysfunction in primary hypertension | 000 | 1 | NIH | 3/27/2026 | $42,479 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AG093208 | The Effect of DDX41 Mutations on Hematopoiesis During Aging | 001 | 1 | NIH | 4/3/2026 | $5,185 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | T2331569 | Children's Hospitals Graduate Medical Education Payment Program | 10 | 8 | HRSA | 3/17/2026 | $608,864 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | T2331569 | Children's Hospitals Graduate Medical Education Payment Program | 10 | 8 | HRSA | 3/17/2026 | $859,938 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K08DK134884 | Commensal bacterial metabolism of dietary phytate in host defense | 000 | 4 | NIH | 4/3/2026 | $155,158 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | T32AI165396 | Vaccinology Training Program | 000 | 5 | NIH | 3/5/2026 | $291,814 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI184466 | Naive CD8 T cell functional heterogeneity | 000 | 2 | NIH | 2/9/2026 | $658,849 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI123176 | Innate mechanisms of regulation of Th17 responses | 000 | 10 | NIH | 1/7/2026 | $477,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK133198 | Cutaneous biomarkers of pediatric non-alcoholic fatty liver disease | 000 | 5 | NIH | 3/6/2026 | $569,533 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD118540 | Understanding functions of LTR retrotransposon activation in preimplantation development | 000 | 2 | NIH | 3/10/2026 | $401,927 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD068524 | Molecular signaling in uterine receptivity to implantation | 002 | 14 | NIH | 2/27/2026 | $439,064 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS132504 | Advancing CNS drug delivery via epigenetic modulation | 001 | 4 | NIH | 3/20/2026 | $56,853 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21HD118147 | Neural Crest Regulation of Embryonic Calcium Uptake | 000 | 2 | NIH | 2/26/2026 | $240,750 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21CA300922 | Pancancer discovery and exploration of shared splicing neoantigens | 000 | 2 | NIH | 2/27/2026 | $187,584 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01CA271455 | Dissecting innate immune signaling in pre-leukemia evolution | 000 | 5 | NIH | 3/2/2026 | $638,243 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL105924 | Thrombospondin 4 regulates adaptive ER stress responseRenewal - Resubmission - 1 | 000 | 15 | NIH | 2/24/2026 | $566,138 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL172346 | Effects of early Retinoic Acid signaling on valve development | 000 | 3 | NIH | 2/24/2026 | $42,479 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 003 | 4 | NIH | 2/24/2026 | $135,660 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL137766 | Molecular Mechanisms of Atrial Development and Regeneration | 000 | 8 | NIH | 2/23/2026 | $538,341 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 002 | 4 | NIH | 2/23/2026 | $62,634 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K23DK135797 | Disrupted sleep architecture in adolescents with functional abdominal pain disorders | 000 | 4 | NIH | 3/3/2026 | $190,307 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL166245 | Defining PRC2 complex epigenomic control in alveolar progenitor cells | 001 | 4 | NIH | 3/31/2026 | $17,447 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL158100 | Effect of reproductive history on longitudinal change in cardiac, vascular and lipid parameters | 001 | 5 | NIH | 3/30/2026 | $20,322 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R00HL171830 | Frontiers at the edge: Subpleural fibroblasts orchestrate pulmonary fibrosis progression | 000 | 3 | NIH | 4/6/2026 | $249,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21CA299166 | Mechanisms underlying increased risk of hematological malignancy in sickle cell disease. | 000 | 2 | NIH | 4/7/2026 | $187,584 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL167200 | Role of apoE in HDL-mediated enhanced survival of human regulatory T-cells | 001 | 4 | NIH | 3/13/2026 | $19,879 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK132043 | Contributions of the enterocyte brush border to intestinal health and disease | 000 | 4 | NIH | 4/7/2026 | $481,632 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI186611 | Viral and Cellular Determinants of HIV-1 Assembly | 000 | 3 | NIH | 4/1/2026 | $609,012 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD116852 | The role of HLA-C in chronic chorioamnionitis | 001 | 2 | NIH | 4/2/2026 | $61,497 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K23HL179415 | Longitudinal Examination of Food Insecurity and Cardiometabolic Health Risk in Hispanic/Latino Adolescents | 000 | 1 | NIH | 4/2/2026 | $191,636 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL164418 | MEOX2: A Critical Regulator of Alveolar Fibroblast Function | 000 | 2 | NIH | 4/1/2026 | $707,389 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01EY034565 | Optimizing methotrexate use for the management of chronic pediatric non-infectious uveitis | 000 | 4 | NIH | 4/6/2026 | $560,861 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R35HL171346 | Transcriptional and epigenetic mechanisms of alveologenesis and re-alveologenesis | 000 | 3 | NIH | 3/20/2026 | $1,099,905 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | U01AI152034 | Atopic dermatitis: mechanisms of disease progression | 001 | 7 | NIH | 4/1/2026 | $224,999 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R35GM158164 | Molecular basis of circadian and sensory integration in neuronal clocks | 000 | 2 | NIH | 4/2/2026 | $401,250 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21AI191085 | Development and application of pediatric-specific blood transcriptional modules across diverse geographical settings through public data mining | 000 | 2 | NIH | 4/1/2026 | $160,264 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 006 | 4 | NIH | 4/2/2026 | -$680,919 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R35GM158075 | Mechanisms of Homeodomain Transcription Factor Specificity | 000 | 2 | NIH | 4/2/2026 | $510,390 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD110321 | Screen Smart: Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department | 000 | 4 | NIH | 4/2/2026 | $769,815 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD114702 | Food-based Randomized trial for Enhancing Support of Hospitalized children and their families (FRESH) | 001 | 2 | NIH | 3/26/2026 | $67,300 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL172839 | Acetylation Regulates YAP Subcellular Localization and Cardiac Regeneration | 001 | 2 | NIH | 3/24/2026 | $15,772 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01CA278834 | The role of DNAJB1-PKAc-β-catenin axis in fibrolamellar HCC | 000 | 4 | NIH | 3/24/2026 | $622,939 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL167700 | Pathogenesis of Vascular Anomalies with GNAQ mutations | 000 | 3 | NIH | 3/23/2026 | $581,713 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS028840 | Mitogenic Activities in Neurofibromatosis | 000 | 34 | NIH | 3/31/2026 | $607,383 |
|
